All In Biotech

Drug Trial Radar · NCT02492841

Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth

Controlled Clinical Trial of the Effect of Calcium Hydroxide, Mineral Trioxide Aggregate (MTA) and Biodentine (Trademark) as Direct Pulp Capping Materials of Permanent Teeth Affected by Caries, in Children From 7 to 16 Years

Last checked: Nov 19, 2026Latest source record: May 30, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 169 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

169

Actual

Start

Apr 2014

Primary completion

Apr 2016

Study completion Aug 2016

Sponsor

Lead sponsor
Universidad de los Andes, ChileAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 9, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 7 years, up to 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Background: Dental caries is considered an oral health problem worldwide. In Chile the last national epidemiological study (2007) showed a national prevalence of dental caries in children 6 years (70.3%) and 12 (62.5%). Direct pulp capping is a preventive dental therapy, keeps the vitality of the tooth using some inductive materials mineralized tissue formation. Objective: The main objective of this study is to evaluate the effectiveness of two innovative direct pulp capping materials; Biodentine compared MTA and calcium hydroxide in the maintenance of pulp vitality in teeth permanent molars.

Conditions

  • Caries
  • Dental Pulp Exposure

Interventions

  • Mineral trioxide aggregateDrug

    Mineral trioxide aggregate

  • Calcium hydroxideDrug

    Classic calcium hydroxide root canal repair material. Inorganic compound (CA(OH)2. It is the gold standard direct pulp cupping material.

  • BiodentineDrug

    Biodentine (trademark). Septodont. Biodentine root canal repair material. A predose capsule plus five drops of calcium chloride solution.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Parameters Evaluated After TreatmentTime frame: 3 months, 6 moths and 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centro de Salud de San Bernardo Universidad de Los Andes

    Santiago, Chile

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.